ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /
Abstract: FR-PO502

Single-Nucleus Transcriptomics Reveal Cell Type-Specific Diversification in Left Ventricle in Mice Undergoing Arteriovenous Fistula Creation with Cardiac-Specific Overexpression of PDE5A

Session Information

  • Dialysis Vascular Access
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 803 Dialysis: Vascular Access

Authors

  • Collie, Paul C., The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Nguyen, Nguyen TN., The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Isayeva Waldrop, Tatyana, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Ptacek, Travis, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Ingle, Kevin Andrew, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Wang, Lingyun, The University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Lee, Timmy C., The University of Alabama at Birmingham, Birmingham, Alabama, United States
Background

PDE5A, an enzyme that hydrolyses cyclic guanosine phosphate (cGMP), has been implicated in various cardiovascular conditions. We have observed an increase in protein levels of cardiac PDE5A following arteriovenous fistula (AVF) creation in left ventricle (LV) (Fig.1-A). AVF creation has been associated with increased cardiac output and dilation of LV leading to adverse cardiac remodeling (Fig.1-B). We performed single nuclei RNA-seq to understand the cellular transcriptional profiles and pathway changes after AVF creation and the role of PDE5A in LV remodeling.

Methods

AVF’s were created in cardiomyocyte-specific overexpression PDE5A transgenic mice (homozygous, HO) and littermate controls (WT). LVs were collected at day 7. Single nuclei RNA-seq was performed to identify gene signatures in WT (n=5), WT-AVF (n=4), HO (n=5), and HO-AVF (n=4) groups. Integration of Single Nuclei data (10X Chromium) was done using Seurat v.4 package.

Results

We observed 19 different clusters, including 9 subtypes of cardiomyocytes (CM). Two CM clusters were not present in AVF group (Fig.1-C). There was a significant increase in endothelial cell count following AVF creation (p=3.2e-3). Notable gene expression changes include a downregulation in genes related to oxidative phosphorylation and ATP production (p=3.2e-18), an upregulation in genes linked to cardiomyocyte death and oxidative stress pathways (p=5.65e-310), downregulation in genes essential for sarcomere assembly and myofibrillogenesis (p=1.22e-190), and downregulation in genes essential for autophagy (p=1.153e-38), cytokines and inflammatory response (p=1.16e-99).

Conclusion

Our snRNA-seq data indicates that AVF creation and PDE5A expression in cardiomyocytes contribute to cardiac impairment pathways and adverse remodeling.

Funding

  • NIDDK Support